188 related articles for article (PubMed ID: 34376214)
1. National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis.
Zhang H; Garcia C; Yu W; Knoll MD; Lai X; Xu T; Jing R; Qin Y; Yin Z; Wahl B; Fang H
BMC Med; 2021 Aug; 19(1):181. PubMed ID: 34376214
[TBL] [Abstract][Full Text] [Related]
2. Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis.
Lai X; Garcia C; Wu D; Knoll MD; Zhang H; Xu T; Jing R; Yin Z; Wahl B; Fang H
Lancet Reg Health West Pac; 2023 Mar; 32():100666. PubMed ID: 36785861
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.
Le P; Griffiths UK; Anh DD; Franzini L; Chan W; Swint JM
Vaccine; 2015 Aug; 33(36):4639-46. PubMed ID: 26044493
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China.
Ning G; Yin Z; Li Y; Wang H; Yang W
Hum Vaccin Immunother; 2018 Jan; 14(1):36-44. PubMed ID: 29049002
[TBL] [Abstract][Full Text] [Related]
5. Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.
Gargano LM; Hajjeh R; Cookson ST
Prehosp Disaster Med; 2015 Aug; 30(4):402-11. PubMed ID: 26061190
[TBL] [Abstract][Full Text] [Related]
6. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.
Levine OS; Ortiz E; Contreras R; Lagos R; Vial P; Misraji A; Ferreccio C; Espinoza C; Adlerstein L; Herrera P
Am J Epidemiol; 1993 Jun; 137(11):1221-8. PubMed ID: 8322763
[TBL] [Abstract][Full Text] [Related]
7. Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.
Clark AD; Griffiths UK; Abbas SS; Rao KD; Privor-Dumm L; Hajjeh R; Johnson H; Sanderson C; Santosham M
J Pediatr; 2013 Jul; 163(1 Suppl):S60-72. PubMed ID: 23773596
[TBL] [Abstract][Full Text] [Related]
8. An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia.
Miller MA
Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S152-9. PubMed ID: 9781750
[TBL] [Abstract][Full Text] [Related]
9. Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs.
Wang J; Zhang H; Zhang H; Fang H
Hum Vaccin Immunother; 2022 Dec; 18(7):2090162. PubMed ID: 35816415
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
Broughton EI
J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
[TBL] [Abstract][Full Text] [Related]
11. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya.
Akumu AO; English M; Scott JA; Griffiths UK
Bull World Health Organ; 2007 Jul; 85(7):511-8. PubMed ID: 17768499
[TBL] [Abstract][Full Text] [Related]
13. Utilization pattern of Haemophilus influenza type b vaccine in eight provinces of China.
Li Y; Yue C; Wang Y; Zhu X; Martin K; Scherpbier RW; Liu J; Wang Z; Ma Y; Cheng H; Zhang Z; Wang Q; Li H; Xie S; Xiao Q; Wang H; An Z
Hum Vaccin Immunother; 2018 Apr; 14(4):894-899. PubMed ID: 29300680
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.
Gupta M; Prinja S; Kumar R; Kaur M
Health Policy Plan; 2013 Jan; 28(1):51-61. PubMed ID: 22407018
[TBL] [Abstract][Full Text] [Related]
15. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants.
Griffiths UK; Clark A; Hajjeh R
J Pediatr; 2013 Jul; 163(1 Suppl):S50-S59.e9. PubMed ID: 23773595
[TBL] [Abstract][Full Text] [Related]
17. Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.
Zhou F; Bisgard KM; Yusuf HR; Deuson RR; Bath SK; Murphy TV
Pediatrics; 2002 Oct; 110(4):653-61. PubMed ID: 12359777
[TBL] [Abstract][Full Text] [Related]
18. A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan.
Kitano T; Aoki H
Vaccine; 2021 Jan; 39(2):343-349. PubMed ID: 33280853
[TBL] [Abstract][Full Text] [Related]
19. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
[TBL] [Abstract][Full Text] [Related]
20. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
Constenla D; Liu T
Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]